Global Health Impact Map

Global Health Impact Map


Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)

Key Contact: Dr. James D. Neaton | Visit Activity Website

Country(ies): Liberia


Contact Information

2221 University Avenue SE Room 200 Minneapolis MN 55414
Work Phone: 612-626-9040
Work Email: neato001@umn.edu

Activity Description

Ebola virus disease (EVD) is spreading in West Africa and there is a critical need for a vaccine to prevent EVD. A large randomized clinical trial is needed to rapidly evaluate candidate Ebola virus vaccines that have completed phase 1 testing. The two vaccines to be studied are the ChAd3-EBO Z vaccine and the VSV ∆ G- ZEBOV vaccine.

Activity Types

Research

Academic Health Center Units

School of Public Health
     Biostatistics

Other Collaborators

Leidos Biomedical Research

Partner Organizations

The Liberian Ministry of Health and Social Welfare , NIH, CDC, GlaxoSmithKline, Merck/ NewLink

Sponsors

National Institutes of Health

Activity Topics

Communicable Disease, Immunization

Status

Current